Skip to content
777 Sourcing.

Capability

intranasal drug development

Suppliers
1
States & provinces
1
Countries
1

1 intranasal drug development supplier across 1 states and provinces in 1 country. Profiles show capabilities, materials, certifications, and facility locations so you can compare shops and build a shortlist.

Suppliers

AURAVAX THERAPEUTICS, INC.

HOUSTON, TX

AuraVax Therapeutics, Inc. is commercializing its intranasal platform called NanoSTING to treat and prevent respiratory infections independent of the pathogen. NanoSTING technology activates the STING pathway to restore and boost innate immunity. The company is developing its technology as a new class of host-directed-therapeutics to treat infections from respiratory pathogens, and is also pursuing NanoSTING to improve intranasal vaccines.

host-directed therapeuticsvaccine adjuvant development

Compiled from public sources

Related capabilities

Other processes offered by the shops that list intranasal drug development.

Browse all capabilities